IPO Boutique

Rani Therapeutics Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Rani Therapeutics Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Rani Therapeutics Inc.RANI -
NASDAQ
$14.00-$16.00 $11.00 $11.266.67 million7/30/2021
BofA Securities, Stifel, Cantor, Canaccord Genuity
Co-Manager(s):
BTIG
Health Care
Filing(s):

Filed 2021-07-09
Terms Added 2021-07-26



Rani Therapeutics Inc. Quote & Chart - Click for current quote - RANI

About Rani Therapeutics Inc. (adapted from Rani Therapeutics Inc. prospectus):
They are a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics, which we believe will have the potential to transform medicine and improve patient outcomes

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "RANI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved